Analyst Ratings for Acadia Pharmaceuticals (ACAD)

ACAD Rating Summary

ACAD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ACAD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $29.67 (+73.4%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/16/2022 Canaccord Genuity Sumant Kulkami Upgrade Buy
(Hold)
31.00
(30.00)
22.27
(17.11)
-23.17% Details
2/9/2022 H.C. Wainwright Andrew S. Fein Upgrade Buy
(N/A)
36.00
(18.00)
25.13
(17.11)
-31.91% Details
Like ACAD Ratings? Also take a look at RMO, INTZ, STOK, AMLX

ACAD Ratings News